BRIC (Bordeaux of Institute of Oncology)

Débuté en 2018, le projet de structuration de la cancérologie à Bordeaux vient d’aboutir à la création de l’Unité Inserm U1312 BRIC au sein du Département Sciences Biologiques et Médicales. Labellisée par l’Inserm et l’Université de Bordeaux, cette unité de recherche rassemble toutes les forces actuelles de la recherche en cancérologie, à savoir les anciennes unités U1218, U1035, U1053, U1029 et EA 7435. Ce sont donc 11 équipes et plus de 230 personnes qui composent maintenant cette nouvelle Unité.

Site Web

Lien scanR

Parcourir par

Auteurs Titres Tutelles Disciplines Date

	2021	2022	2023	2024	2025
Actes de congrès/Proceedings	0	0	0	0	0
Article de blog scientifique	0	0	0	0	0
Article de revue	1	5	5	17	3
Autre document	0	0	0	0	0
Brevet	0	0	0	0	0
Chapitre d'ouvrage	0	0	0	0	0
Communication dans un congrès	0	0	0	0	0
Document de travail - Pré-publication	0	0	0	1	0
HDR	0	0	0	0	0
Notice d'encyclopédie ou de dictionnaire	0	0	0	0	0
N°spécial de revue/special issue	0	0	0	0	0
Ouvrage	0	0	0	0	0
Poster	0	0	0	0	0
Rapport	0	0	0	1	0
Thèse d'exercice	0	0	0	0	0
Thèses de doctorat	0	1	0	0	0
Traduction	0	0	0	0	0

BRIC (Bordeaux of Institute of Oncology) - U1312

Parcourir par

Dépôts récents

Exploiting Metabolic Vulnerability in Glioblastoma Using a Brain-Penetrant Drug with a Safe Profile

Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study)

Emerging role of oncogenic ß-catenin in exosome biogenesis as a driver of immune escape in hepatocellular carcinoma

DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis

Cell-Permeable Peptide Inhibitors of the p53-hDM2 Interaction via Foldamer Helix Mimicry and Bis-Thioether Stapling

Avis de l’Anses relatif à l’élaboration de lignes directrices pour l’évaluation des risques environnementaux liés à la dissémination volontaire de médicaments à usage humain ou vétérinaire contenant des organismes génétiquement modifiés ou consistant en de tels organismes

Actualités 2024 par le Comité dé rédaction du Bulletin du Cancer : congrès ASCO, ESMO et au-delà

Advanced viral genome in vitro Cas9 editing (AdVICE): an overnight method for traceless and limitless manipulation of adenoviral and vector genomes with large transgenes

A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomas

Glucuronide metabolites of trans-ϵ-viniferin decrease triglycerides accumulation in an in vitro model of hepatic steatosis

Targeting metastasis-initiating cancer stem cells in gastric cancer with leukaemia inhibitory factor

Early use of hybrid closed-loop following total pancreaticoduodenectomy.

Classification of PTEN germline non-truncating variants: a new approach to interpretation

Comparison of the molecular FluoroType Mycobacteria VER 1.0 and the Maldi BioTyper Mycobacteria assays for the identification of non-tuberculous mycobacteria.

Case report: Unveiling genetic and phenotypic variability in Nonketotic hyperglycinemia: an atypical early onset case associated with a novel variant.

Rethinking care management for older adults with cancer: Proposals from the "PRIORITES AGE CANCER" French group

Bacteraemia associated with multiple septic localizations caused by Klebsiella pneumoniae sequence type ST660.

CXCL10-dependent epithelial-vascular cross-talk for endothelial activation following Sars-CoV-2 infection

Clinical impact of proton pump inhibitors and other co-medications on advanced melanoma patients treated with BRAF/MEK inhibitors

Effect of Peg-IFN on the viral kinetics of HDV infected patients treated with bulevirtide

Statistiques

Statistiques générales de la collection

Nombre de documents par année

Dépôs récents

BRIC (Bordeaux of Institute of Oncology) - U1312

Parcourir par

Dépôts récents

Exploiting Metabolic Vulnerability in Glioblastoma Using a Brain-Penetrant Drug with a Safe Profile ﻿

Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study) ﻿

Emerging role of oncogenic ß-catenin in exosome biogenesis as a driver of immune escape in hepatocellular carcinoma ﻿

DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis ﻿

Cell-Permeable Peptide Inhibitors of the p53-hDM2 Interaction via Foldamer Helix Mimicry and Bis-Thioether Stapling ﻿

Avis de l’Anses relatif à l’élaboration de lignes directrices pour l’évaluation des risques environnementaux liés à la dissémination volontaire de médicaments à usage humain ou vétérinaire contenant des organismes génétiquement modifiés ou consistant en de tels organismes ﻿

Actualités 2024 par le Comité dé rédaction du Bulletin du Cancer : congrès ASCO, ESMO et au-delà ﻿

Advanced viral genome in vitro Cas9 editing (AdVICE): an overnight method for traceless and limitless manipulation of adenoviral and vector genomes with large transgenes ﻿

A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomas ﻿

Glucuronide metabolites of trans-ϵ-viniferin decrease triglycerides accumulation in an in vitro model of hepatic steatosis ﻿

Targeting metastasis-initiating cancer stem cells in gastric cancer with leukaemia inhibitory factor ﻿

Early use of hybrid closed-loop following total pancreaticoduodenectomy. ﻿

Classification of PTEN germline non-truncating variants: a new approach to interpretation ﻿

Comparison of the molecular FluoroType Mycobacteria VER 1.0 and the Maldi BioTyper Mycobacteria assays for the identification of non-tuberculous mycobacteria. ﻿

Case report: Unveiling genetic and phenotypic variability in Nonketotic hyperglycinemia: an atypical early onset case associated with a novel variant. ﻿

Rethinking care management for older adults with cancer: Proposals from the "PRIORITES AGE CANCER" French group ﻿

Bacteraemia associated with multiple septic localizations caused by Klebsiella pneumoniae sequence type ST660. ﻿

CXCL10-dependent epithelial-vascular cross-talk for endothelial activation following Sars-CoV-2 infection ﻿

Clinical impact of proton pump inhibitors and other co-medications on advanced melanoma patients treated with BRAF/MEK inhibitors ﻿

Effect of Peg-IFN on the viral kinetics of HDV infected patients treated with bulevirtide ﻿

Statistiques

Statistiques générales de la collection

Nombre de documents par année

Dépôs récents

Exploiting Metabolic Vulnerability in Glioblastoma Using a Brain-Penetrant Drug with a Safe Profile

Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study)

Emerging role of oncogenic ß-catenin in exosome biogenesis as a driver of immune escape in hepatocellular carcinoma

DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis

Cell-Permeable Peptide Inhibitors of the p53-hDM2 Interaction via Foldamer Helix Mimicry and Bis-Thioether Stapling

Avis de l’Anses relatif à l’élaboration de lignes directrices pour l’évaluation des risques environnementaux liés à la dissémination volontaire de médicaments à usage humain ou vétérinaire contenant des organismes génétiquement modifiés ou consistant en de tels organismes

Actualités 2024 par le Comité dé rédaction du Bulletin du Cancer : congrès ASCO, ESMO et au-delà

Advanced viral genome in vitro Cas9 editing (AdVICE): an overnight method for traceless and limitless manipulation of adenoviral and vector genomes with large transgenes

A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomas

Glucuronide metabolites of trans-ϵ-viniferin decrease triglycerides accumulation in an in vitro model of hepatic steatosis

Targeting metastasis-initiating cancer stem cells in gastric cancer with leukaemia inhibitory factor

Early use of hybrid closed-loop following total pancreaticoduodenectomy.

Classification of PTEN germline non-truncating variants: a new approach to interpretation

Comparison of the molecular FluoroType Mycobacteria VER 1.0 and the Maldi BioTyper Mycobacteria assays for the identification of non-tuberculous mycobacteria.

Case report: Unveiling genetic and phenotypic variability in Nonketotic hyperglycinemia: an atypical early onset case associated with a novel variant.

Rethinking care management for older adults with cancer: Proposals from the "PRIORITES AGE CANCER" French group

Bacteraemia associated with multiple septic localizations caused by Klebsiella pneumoniae sequence type ST660.

CXCL10-dependent epithelial-vascular cross-talk for endothelial activation following Sars-CoV-2 infection

Clinical impact of proton pump inhibitors and other co-medications on advanced melanoma patients treated with BRAF/MEK inhibitors

Effect of Peg-IFN on the viral kinetics of HDV infected patients treated with bulevirtide